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ABSTRACT The possible relationship of selenium to im-
munological function which has been suggested for decades
was investigated in studies on selenuim metabolism in human
T cells. One of the major 75Se-labeled selenoproteins detected
was purified to homogeneity and shown to be a homodimer of
55-kDa subunits. Each subunit contained about 1 FAD and at
least 0.74 Se. This protein proved to be thioredoxin reductase(TR) on the basis of its catalytic activities, cross-reactivity
with anti-rat liver TR antibodies, and sequence identities of
several tryptic peptides with the published deduced sequence
of human placental TR. Physicochemical characteristics of
T-cell TR were similar to those of a selenocysteine (Secys)-
containing TR recently isolated from human lung adenocar-
cinoma cells. The sequence of a 12-residue 75Se-labeled tryptic
peptide from T-cell TR was identical with a C-terminal-
deduced sequence of human placental TR except that Secys
was present in the position corresponding to TGA, previously
thought to be the termination codon, and this was followed by
Gly-499, the actual C-terminal amino acid. The presence of the
unusual conserved Cys-Secys-Gly sequence at the C terminus
ofTR in addition to the redox active cysteines of the Cys-Val-
Asn-Val-Gly-Cys motif in the FAD-binding region may ac-
count for the peroxidase activity and the relatively low sub-
strate specificity of mammalian TRs. The finding that T-cell
TR is a selenoenzyme that contains Se in a conserved C-
terminal region provides another example of the role of
selenium in a major antioxidant enzyme system (i.e., thiore-
doxin-thioredoxin reductase), in addition to the well-known
glutathione peroxidase enzyme system.
Selenium is a trace element that is important for a number of
physiological processes and for human health. Its essentiality
is based on the fact that it is a specific component of Se-
dependent enzymes and tRNAs. In known Se-dependent
enzymes Se occurs as an active center amino acid residue,
selenocysteine (Secys) (1, 2) or as a metal-coordinated labile
cofactor (3, 4). In both cases Se is essential for the catalytic
activities exhibited by the specific selenoenzymes. The mech-
anism of incorporation of Secys is established for prokaryotes(5), and many aspects of its incorporation in eukaryotic
proteins are well understood (6).
The UGA codon directs incorporation of this amino acid
residue both in prokaryotes and eukaryotes. In addition,
conserved stem-loop structures immediately following UGA
in prokaryotes (5) and in 3'-untranslated regions in eukaryotes(7) function as determinants of Secys incorporation instead of
termination of translation.
Among eukaryotic proteins that contain Se as a Secys
residue, the most studied are members of the glutathione
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peroxidase family (8). These enzymes that catalyze the gluta-
thione- or thioredoxin-dependent reduction of hydroperoxides
are important intra- and extracellular antioxidants in mammals
and birds. A different metabolic role of selenium was estab-
lished by the discovery of the selenium-dependent 5' deiodi-
nases (9). These enzymes function in the synthesis and main-
tenance of optimal levels of essential thyroid hormones required
for growth and development. Selenoproteins of unknown func-
tion include selenoprotein P, the major plasma selenoprotein (10)
that contains 10 Secys residues and selenoprotein W, a small
Secys-containing protein present in muscle (11).
Recently a new selenoprotein purified from human lung
adenocarcinoma cells was shown to be a homodimer of 57 kDa
subunits containing FAD and Secys (12). This enzyme exhib-
ited thioredoxin reductase (TR) activities similar to those of
human placenta (13) and rat liver (14) TRs. Although the lung
enzyme did not react with anti-rat liver TR antibodies, which
suggests it might be a novel type of TR, it clearly is related to
another form of the enzyme present in the lung cells that is
immunoreactive (S.-Y. Liu and T.C.S., unpublished data).
In view of the fact that selenium has been indirectly impli-
cated in immunological function in numerous nutritional stud-
ies and that HIV-infected individuals are reported to have
decreased levels of plasma Se and selenium-containing gluta-
thione peroxidase (15), we initiated studies on selenium
metabolism in human T cells. Identification of one of the
selenoproteins detected in T cells as TR and demonstration
that the location of Secys in this protein corresponds to a TGA
codon in the cloned human placental gene (16) is reported in
the present communication.
MATERIALS AND METHODS
Materials. The following materials were from the indicated
sources: [75Se]selenious acid from the Research Reactor Fa-
cility (University of Missouri, Columbia); precast polyacryl-
amide gels and molecular weight standards from NOVEX (San
Diego); isoelectrofocusing standards from Pharmacia; ECL
immunoblotting detection system from Amersham; trypsin
and 2',5'-ADP- Sepharose from Sigma; C18 (218TP54) re-
versed-phase HPLC column from Vydac; sulfopropyl (SP)
HPLC column from TosoHaas (Montgomeryville, PA); and
heat-inactivated fetal bovine serum and RPMI 1640 medium
from Mediatech (Herdon, VA). Human thioredoxin, rat liver
thioredoxin reductase, and rabbit polyclonal antibodies to rat
liver thioredoxin reductase were kindly provided by Ho Zoon
Chae (National Institutes of Health). Human lung adenocar-
Abbreviations: Secys, selenocysteine; TR, thioredoxin reductase; SP,
sulfopropyl; DTNB, 5,5'-dithiobis(2-nitrobenzoate); MALDI, matrix-
assisted laser desorption ionization.
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cinoma thioredoxin reductase labeled with 75Se was kindly
provided by Song-Yuan Liu (National Institutes of Health).
All other reagents were of the highest grade available.
Cell Growth. A human Jurkat T-cell line, JPX9 (29), was
grown on RPMI 1640 medium in the presence of 10% fetal
bovine serum and antibiotic-antimycotic solution in 5% C02.
For preparation of 75Se-labeled cells, 12 ,tl of [75Se]selenious
acid, 300 ,tCi (1 Ci = 37 GBq), in 30% nitric acid was added
to 40 ml of medium and cells were grown for 3 days under the
same conditions. Cells were collected by centrifugation,
washed two times with phosphate-buffered saline, and stored
at -80°C prior to use.
TR Purification. For purification of TR, unlabeled cells
were mixed with 75Se-labeled cells. The cells were suspended
in 2 volumes of cold 25 mM Tris-HCl (pH 7.8), 1.5 mM EDTA,
and 2 mM DTT (buffer A) containing 10 ,ug of aprotinin per
ml, 10 jig of leupeptin per ml, 2 mM MgCl2, 1 mM phenyl-
methylsulfonyl fluoride, and 1 mM NaF and were disrupted by
sonication. The pellet, obtained after centrifugation of the
disrupted cells, was washed with a minimal volume of buffer
A and again collected by centrifugation. The supernatants
were combined and applied to a DEAE-Sephadex anion-
exchange column equilibrated with buffer A. The proteins
were eluted with a linear 0-0.4 M gradient of sodium chloride
in buffer A. The radioactivity of fractions containing 75Se was
determined in a Beckman 5500 y counter and the peak
Se-containing fractions were analyzed on SDS gels. Fractions
containing a 55 kDa selenoprotein were combined, diluted
four times with buffer A, and applied to a 2',5'-ADP Sepharose
affinity column equilibrated with buffer A. The column was
washed sequentially with buffer A, 0.2 M sodium chloride in
buffer A, 0.3 M sodium chloride in buffer A, and 1 M sodium
chloride in buffer A. The TR detected as a 75Se-containing
protein was eluted with 1 M NaCl in buffer A. Ammonium
sulfate (4 M, pH 8.0), was added to the enzyme solution to a
final concentration of 0.5 M and the TR solution was applied
to a phenyl-Sepharose column and eluted with a linear 0.5-0 M
gradient of ammonium sulfate in 25 mM Tris-HCI (pH 7.8). The
resulting 75Se-labeled TR that eluted at 0.2M ammonium sulfate
was concentrated to about 1 mg/ml and stored at -20°C.
Carboxymethylation and Tryptic Digestion of TR. 75Se-
labeledTR (100 Lzg, 3 x 105 cpm) in 160 tl of 100mM Tris-HCl(pH 7.7) and 6 mM EDTA was denatured by mixing with 160
mg of dry guanidine-hydrochloride in a 1.5 ml microcentrifuge
tube. The solution was sparged with argon for 20 min and after
the addition of 15 ILl of 100mM DTT the reaction mixture was
incubated for 40 min at room temperature. For alkylation a 33
,xl aliquot of 250 mM iodoacetate was added and the solution
was incubated under argon at room temperature in the dark for
40 min. To quench the reaction, 15 Iul of 1 M DTT was added.
The solution was diluted to 650 ,l with 4 M guanidine-
hydrochloride and dialyzed with two changes against 2 liters of
20 mM Tris-HCl (pH 8.0). The resulting carboxymethylated
TR was mixed in a 1.5 ml microcentrifuge tube with 2.5 pil of
0.66 mg/ml trypsin in 20mM Tris-HCl (pH 8.0) and incubated
at 37°C for 20 h. After 8 h of incubation another 2.5 I1l of the
same trypsin solution was added. Five microliter aliquots of the
digestion mixture were collected at 1 min, 8 h, and 20 h of
incubation and analyzed by SDS/PAGE. Based on the Coo-
massie blue staining of the protein and the PhosphorImager
detection of 75Se in the gel, most of the TR was digested at 8 h,
and digestion was complete at 20 h. After 20 h of incubation
a 75Se-containing peptide appeared as a diffuse 4-kDa species
in SDS gels.
Separation and Sequencing of Se-Containing Peptide. The
tryptic digestion mixture of carboxymethylated TR was acid-
ified with HC1 to pH 2.0, mixed with 600 mg of dry guanidine-
hydrochloride and 5 ,il of 0.5 M DTT, and loaded on a C18
reversed-phase HPLC column, equilibrated in 0.05% triflu-
oroacetic acid. The 100-min gradient of acetonitrile from 0 to
50% in 0.05% trifluoroacetic acid was applied to elute peptides
at 1 ml/min flow rate. A single 75Se-containing peptide (1.53
x 105 cpm) was eluted with 23% acetonitrile. A 35% portion
of the isolated peptide was dried on a SpeedVac SC110(Savant), dissolved in 6M guanidine-hydrochloride and 2 mM
DTT, and subjected to automatic sequencing on a Hewlett-
Packard Protein Sequencer G100A. At each cycle, all eluates
were collected and analyzed for the presence of 75Se by gamma
counting. The remainder of the 75Se-containing peptide was
loaded on a sulfopropyl (SP) HPLC column and eluted with a
gradient from 0 to 0.5 M NaCl in 0.05% trifluoroacetic acid
over a 30-min time period. A 75Se-containing peptide was
eluted as a single peak, centered at 100 mM NaCl, that
separated from the major impurities. This peptide was used
directly for sequencing, and fractions corresponding to each
cycle of the Edman degradation were collected and analyzed
for the presence of 75Se.
Other Methods. Isoelectrofocusing (pH 3-7 range), SDS,
and native PAGE analyses were performed according to
standard procedures using 5%, 12%, or gradient 4-20%
polyacrylamide gels. Gels were stained with Coomassie blue
R-250. For detection of 75Se in gels, a PhosphorImager (Mo-
lecular Dynamics) was used. Thioredoxin- and 5,5'-
dithiobis(2-nitrobenzoate) (DTNB)-dependent assays of cat-
alytic activities were performed as described (12). The sele-
nium content of TR was determined with a Perkin-Elmer
model 4100 ZL atomic absorption spectrometer by using a
palladium/magnesium nitrate modifier and temperature con-
ditions as described (17). The molecular masses of purified TR
and some of the tryptic peptides were determined by matrix-
assisted laser desorption ionization (MALDI) time-of-flight
mass spectrometry with cinapinic acid as a matrix. Analytical
HPLC gel-filtration for the determination of the molecular
mass of the enzyme was performed as described (4). An
immunoblotting procedure with an ECL detection system was
used to study the cross-reactivity of human T-cell TR to
polyclonal rabbit antibodies raised against rat liver TR. For this
experiment, rat liver TR served as a control.
RESULTS
Analysis of extracts of 75Se-labeled human T cells by SDS/
PAGE followed by PhosphorImager detection of radioactivity
revealed the presence of several selenium-containing proteins.
One of the most abundant selenium-containing proteins in the
extracts, detected as a prominent 75Se-labeled 55-kDa protein
band on the gels, was selected for preliminary characterization.
About 40% enrichment of this protein was achieved by using
DEAE Sephadex ion-exchange and phenyl Sepharose hydro-
phobic interaction chromatographic procedures. During these
isolation steps it was observed that a flavin-containing species
coeluted with the 75Se-labeled 55-kDa protein. This suggested
that the T-cell protein might be a TR similar to the Secys-
containing flavoprotein recently isolated from a human lung
adenocarcinoma cell line (12). The lung enzyme, a homodimer
of 57-kDa subunits, contained FAD and exhibited catalytic
activities typical of mammalian TRs. To determine whether
the T-cell selenoprotein is also a TR, the partially purified
enzyme preparation was tested in immunoblot assays for
interaction with anti-rat liver TR polyclonal antibodies. A
strong signal exhibited by a 55-kDa protein band indicated the
presence of TR.
For further purification of the 55-kDa selenoprotein, a
2',5'-ADP Sepharose affinity matrix that has been used rou-
tinely for efficient purification of mammalian TRs (18) was
employed. As judged by SDS and native PAGE analyses (Fig.
1 A and D), an apparently homogeneous preparation of the
enzyme was obtained by the modified isolation procedure
described in Materials and Methods. The purified enzyme
migrated as a 130-kDa species in gradient native PAGE gels
Biochemistry: Gladyshev et al.
































FIG. 1. Characterization of 75Se-labeled 55-kDa T-cell selenoprotein (TR). (A) SDS/PAGE analysis of TR. Lanes 1 and 4, standards; lane 2,
rat liver TR; lane 3, human T-cell TR. Molecular masses of standards (in kDa) are shown. Gradient 4-20% gel was used. (B) PhosphorImager
detection of 75Se in TRs on SDS gel. Lane 1, human lung TR; lane 2, human T-cell TR after DEAE step; lane 3, pure T-cell TR. Molecular masses
of standards (in kDa) are shown. (C) Immunoblot detection of human T-cell TR with anti-rat liver TR antibodies. Lane 1, rat liver TR; lane 2,
T-cell TR. Molecular masses of standards (in kDa) are shown. Gradient 4-20% gel was used. (D) PAGE analysis of native TR. Lane 1, T-cell TR;
lane 2, standards; lane 3, rat liver TR. Molecular masses of standards (in kDa) are shown. Location of homodimeric TR is indicated by the arrow.
Small portions of T cell and rat liver TR migrated also as higher molecular mass aggregates. Gradient 4-20% gel was used.
(Fig. 1D) and the elution position of the protein from a
calibrated gel-filtration column corresponded to a 120-kDa
species (data not shown). These properties indicate that the
native selenoenzyme is a homodimer of 55-kDa subunits, a
structure typical of mammalian TRs.
On SDS/PAGE gels the enzyme migrated as two barely
separating protein bands that are approximately equally
stained with Coomassie blue (Fig. 1A). Both bands showed
about equal intensity of 75Se radioactivity (Fig. 1B). To avoid
generation of isoforms by proteolysis during purification,
several protease inhibitors had been added to cells prior to
sonic disruption. Size differences due to partial N-terminal
proteolytic cleavage seemed unlikely since all protein mole-
cules in the native enzyme preparation were N-blocked asjudged by Edman degradation sequence analysis. Also, based
on the fact that the human lung TR selenoprotein was shown
to lack glycosyl groups (12), differences due to varying states
of glycosylation of the T-cell enzyme appeared very unlikely.
The isolated human lungTR also was N-blocked. In some cases
the presence of isoforms of differing net charge can explain the
separation of the protein bands in gels. Such differences can be
reflections of the presence of covalent modifying groups or
protein alteration due to oxidative damage. However, although
the apparently homogeneous preparation of the lung TR
contained two protein species of differing isoelectric points,
pH 5.2 and pH 5.3 (12), it migrated in SDS gels as a single
protein band. The purified T-cell TR showed isoforms ranging
in pI values from 5.15 to 5.35 when analyzed using a pH 3-7
isoelectric focusing gel (not shown). As controls another
preparation of the human lung TR that had been isolated by
a different procedure and rat liver TR were run on the same
gel. The pI values of the lung enzyme varied from 5.1 to 5.4,
whereas a single isoform with a pI value of 5.85 was detected
in the rat liver enzyme. The basis of these differing isoelectric
points of protein species present in the various enzyme prep-
arations is unknown.
MALDI mass spectrometric analysis of the native T-cell
enzyme revealed the presence of a single polypeptide subunit
with a molecular mass of a 56,018 Da. This mass is significantly
larger that the predicted value of 54,625 Da for the mass of the
499-amino acid polypeptide. Although the identity of the
group present at the blocked amino terminus is unknown, it is
unlikely to be of a size sufficient to account for the difference
in mass. Whether tightly bound cofactors such as the FAD
present in the enzyme are resolved during MALDI analysis
appears to be unpredictable and highly subject to precise
conditions used.
The purified T-cell TR cross-reacted with the anti-rat liver
TR antibodies in the immunoblot assay (Fig. 1C) and both of
the protein bands detected on SDS gels appeared to be equally
reactive. The TR isolated from human lung adenocarcinoma
cells by a different procedure that involved absorption and
elution from a heparin-agarose affinity matrix failed to react
with the same antibody preparation (12). However, it now
appears that a second form of the enzyme also is present in the
lung cells, and this protein is recognized by the anti-rat liverTR
antibodies in the immunoblot assay (S.-Y. Liu and T.C.S.,
unpublished).
The isolated T-cell enzyme exhibited catalytic activities
typical of mammalian TRs. NADPH-dependent reduction of
DTNB and human thioredoxin-dependent reduction of insulin
with activities of 25 and 19 ,mol NADPH oxidized/min/mg
protein, respectively, were observed. These values are in the
range of those reported for mammalian TRs from other
sources (12-14, 19-21).
The electronic absorption spectrum of the T-cell TR re-
vealed a characteristic flavin profile. The ratio of absorptivities
at 280 nm and 450 nm was found to be 10 (ratio of absorp-
tivities at maxima of 277 nm and 466 nm was 9), which is typical
of mammalian TRs and indicative of an approximately full
complement of FAD (two flavins per homodimer).
The amount of Se in T-cell TR determined by graphite
furnace atomic absorption spectroscopy was 0.74 Se per 55-
kDa subunit. The lower then stoichiometric amount of Se in
T-cell TR presumably is due to the inaccuracies of determi-
nation of Se in proteins of similar molecular masses. Thus the
T-cell TR probably contains 1 Se per enzyme subunit.
To determine the location of selenium in the human T-cell
TR, the reduced 75Se-labeled enzyme was carboxymethylated
and cleaved with trypsin followed by separation of peptides on
a reversed-phase HPLC column (Fig. 2). The 75Se was eluted
from the column in fractions of a single major radioactive
peak. Further purification using a SP HPLC column separated
the 75Se-labeled peptide from the major impurities (data not
shown). The overall high (about 50%) recovery of 75Se in the
resulting purified carboxymethylated peptide suggested the
presence of a single stable selenium moiety, presumably
carboxymethyl-selenocysteine.
The purified 75Se-labeled peptide isolated from the SP
HPLC column was subjected to automated Edman degrada-
tion N-terminal sequencing analysis. Fractions corresponding
to each cycle of the degradation were collected and analyzed
for radioactivity. The resulting unique amino acid sequence
matched exactly the deduced C-terminal 10-residue sequence
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---. ---_DISCUSSION
A 12-residue 75Se-labeled tryptic peptide isolated from human
T-cell TR was shown to contain Secys in the position corre-}·)~~~~~~~ ~~~~sponding to a TGA codon in the human placental TR gene.
,] ~The entire amino acid sequence of the peptide was identical to
that predicted from the gene sequence plus an additional twolI 1XE~ residues, Secys and glycine. In the reported placental gene
-^I i'' !1 ;- - sequence (16), TGA had been interpreted as a termination
XI, ! < codon, but from our studies it is clear that this TGA encodes
") .. j..'* 'i i't . "Secys. The corresponding locations of Secys in the peptide and
..il lI ji i; l l the TGA codon in the gene clearly indicate that the seleno-) -' I t .........l !|6i. 1..;.l-'j','*,," .fi.:.J_ amino acid is specifically incorporated cotranslationally as
-1sl!_t^i',J,-"ls^t_'':.. ' ^ ..-t...directed by UGA.
.1--*-*---- c-- ' -'-........--.,. The finding that T-cell TR contains a C-terminal amino acid
30 40 50 60 70 80 90 sequence, Cys-Secys-Gly, is particularly interesting. This rel-
Fraction number atively rare occurrence of Secys adjacent to a cysteine residue,
and in this case only one residue removed from the C terminus,
has important implications concerning its accessibility for
possible interaction with disulfide substrates during catalysis.Reversed-phase HPLC separation of a tryptic digest of In view of the fact that a sulfur analog of the enzyme with amethylated 75Se-labeled TR. The tryptic digest of T-cell TR deduced C-terminal seuence of s-s-Gl resumabl ex-
)matographed on a C18 column developed with a gradient of deduced suenceof CyG presumably ex-
rile in 0.05% trifluoroacetic acid. Elution of peptides was ists in Caenorhabditis elegans (22), the catalytic activities of the
i by absorptivity at 214 nm (shown in arbitrary units) and by two pure enzymes will be very interesting to compare. In
nation of 75Se in collected fractions. contrast to the Secys-containing enzyme, overproduction of
the naturally occurring cysteine mutant form should not be
ental TR derived from the cloned cDNA (16), except difficult.
e peptide contained two additional residues at the C Human placental TR shares a strong homology with other
Is (Table 1). The 75Se in the peptide was eluted in cycle NADPH-dependent FAD-containing oxidoreductases includ-
re no amino acid was identified and this corresponded ing human and Escherichia coli glutathione reductases,
TGA codon in the gene. Cycle 12 contained a modest Trypanosoma cruzi trypanothione reductase, C. elegans TR,
t of glycine, and no additional amino acids were de- and dihydrolipoamide dehydrogenase (16). The TRs from E.in cycles 13 and 14. From these data it is apparent that coli and other bacteria, in contrast, lack a strong homology
A codon corresponds to Secys in the protein rather than with the human TR, indicating significant differences in struc-
as a termination codon as was concluded previously ture. Based on detailed studies of glutathione reductases and
hus the three final triplets of the gene, TGAGGT TAA, the strong homology with human TR, it was suggested that the
y encode Secys and a C-terminal glycine with TAA putative N-terminal FAD-binding domain of the latter con-
as the actual termination codon (Table 1). tains the redox active disulfide moiety that is reduced by
sequence of an additional major peptide was deter- transfer of reducing equivalents from NADPH via FAD (16).by Edman degradation analysis of the impure 75Se- Utilization of the resulting dithiol to reduce the disulfide of a
peptide fraction eluted from the reversed-phase HPLC thioredoxin substrate would by analogy involve a conserved(Fig. 2). In addition to the sequence of the 75Se-labeled histidine residue, H472 (Table 2), in the C-terminal region to
lue C-terminal peptide (Ser-488-Gly-499), the se- facilitate the redox transfer. However, in contrast to glutathi-
of another peptide which matched residues Phe-157- one reductase, the human TR contains an additional 16 amino
6 of the predicted gene sequence was clearly discern- acid C-terminal segment that includes the Secys-498 residue
lentity of the latter peptide (expected mass 1159 Da) (Table 2). The precise role of this selenoamino acid, which
nfirmed by MALDI mass spectrometry. Sequences of previously was not known to be present in mammalian TRs,
dditional minor peptides that could be determined from will be interesting to elucidate from a mechanistic point of
uence analysis matched the sites of the deduced pla- view. A possible clue that it is a direct participant in the
FR cDNA spanning Lys-299-Gly-306, Ile-316-Val-326, reduction of disulfide substrates comes from the observation
r-313-Val-326. These data show that peptides compris- that reaction of NADPH-reduced human and calf liver TRs
tal of 44 amino acids from T-cell TR share identity with with 1-chloro-2,4-dinitrobenzene caused rapid and complete
d peptide sequences in placental TR. inactivation of the enzymes with respect to their ability to
Table 1. Comparison of the deduced amino acid sequence of the C-terminal region of human placental TR with the Edman degradation
sequence of a 75Se-labeled tryptic peptide from human T-cell TR
Sequence
Nucleotide sequence of C-terminal region of human TCT-GGG-GCA-AGC-ATC-CTC-CAG-GCT-GGC-TGC-TGA-GGT-TAA
placental TR
Deduced amino acid sequence of C-terminal region of S - G - A - S - I - L - Q - A - G - C -end
human placental TR 488 497
Amino acid sequence of 75Se-labeled tryptic peptide S - G - A - S - I - L - Q - A - G - C*- Ut- G -end
from human T-cell TR
Yields of amino acid residues during Edman 39t-119-130-25 -44 -98 -83 -93 -75 -52 - 6
degradation sequence analysis (pmol)
*Carboxymethylated Cys-497 was determined during Edman degradation based on the elution position of a carboxymethylated cysteine standard.
tU represents Secys. This residue is not detected during Edman degradation.
tYields for serine and isoleucine residues are usually lower than for other residues. The low yield of Gly-499 in cycle 12 is indicative of its poor
binding to the sequencing column because this is the C-terminal residue in the peptide.
Biochemistry: Gladyshev et al.
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Table 2. Alignment of C-terminal regions of human glutathione reductase (GR), human TR, and C.
elegans TR
Sequence
,* * * , ####
Human TR 468 TIGIHPVCAEVFTTLSVTKRSGASILQAGCUG 499
C. elegans TR 468 TIAIHPCSSEEFVKLHITKRSGQDPRTQGCCG 499
Human GR 463 TVAIHPTSSEELVTLR 478
*, Conserved residues in NADPH-dependent disulfide oxidoreductase enzyme family. H467 and E472 of
GR and corresponding residues of other enzymes of this family are involved in interaction with active
center cysteines. #, Conserved C-terminal regions of human and C. elegans thioredoxin reductases. U
represents Secys residue. Numbering in the sequence of human TR starts from the methionine residue
that was suggested to initiate translation (16).
reduce thioredoxin or DTNB, whereas the alkylated enzymes
exhibited greatly increased NADPH oxidase activities (23). In
view of the known high reactivity of ionized selenol groups
with alkylating agents, the Secys residue in the enzymes is the
obvious target. Moreover, the slow rate of reaction of the
alkylating agent with glutathione at pH 7.5 as compared with
the almost 104 times faster rate of inactivation of the enzyme
is consistent with the fact that a selenol is completely ionized
at pH 7.5, whereas the cysteine thiol group of glutathione is
only partially ionized. The ability of the alkylated enzyme to
catalyze transfer of reducing equivalents from NADPH to
oxygen suggests that a normal tightly coupled redox cycle
involving the bound FAD moiety and Secys has been inter-
rupted with the result that oxygen could then serve as direct
electron acceptor for the reduced FAD.
In addition to disulfide-containing proteins such as thiore-
doxin and protein disulfide isomerase (24) that serve as
substrates for mammalian TR, other unrelated substrates for
the enzyme have been reported. These include DTNB, alloxan,
menadione and oxidized lipoamide (14), Secys (25), and
certain lipid hydroperoxides such as oxygenated forms of
arachidonic acid (26). With the latter hydroperoxide sub-
strates, a large rate enhancement of the reduction to the
corresponding alcohols was observed when Secys (50-fold
molar excess over enzyme) was included in the reaction
mixtures. Similar large rate enhancements had been reported(27) for reduction of free and protein bound disulfides by
selenols. The precise mechanism of the TR catalyzed perox-
idase reaction, which presumably involves the Secys residues of
the enzyme (two per protein dimer) together with the excess
ionized free Secys formed enzymatically by reduction of
selenocystine, is not established. In view of the fact that free
Secys is present in biological systems in very low concentra-
tions, the importance of TR as a peroxidase in vivo is unclear.
However, based on these observations, one more type of
antioxidant system with the potential of a protective role in the
cell should be considered.
It is of interest that levels of TR in three different trans-
formed cell lines (12, 19,20) are approximately 10 times higher
than the levels of enzyme reported in bovine liver (21), rat liver(14), human placenta (13), and human T cells. Whereas 3000-
to 4000-fold enrichment was required to obtain homogeneous
enzymes from the mammalian tissues, pure enzyme was ob-
tained from transformed cells after only 150- to 500-fold
enrichment (12, 19,20). Depending on availability of NADPH,
a ready supply of reducing equivalents can be maintained
through the action of TR and this, together with the known
high levels of glutathione in transformed cells, can be impor-
tant factors in the rapid growth of tumors. Since selenium is a
constituent ofTR and other selenoproteins, the amount of this
trace element in unsupplemented culture media may not be
sufficient for the synthesis of the high levels of selenoenzymes
found in transformed eukaryotic cells.
In view of the importance of the thioredoxin-TR system as
a source of reducing equivalents for numerous essential cel-
lular processes such as conversion of ribonucleotides to de-
oxyribonucleotides, reduction of protein disulfide groups and
protein folding, reduction of methionine sulfoxide in proteins
to methionine, reduction of thiol-specific peroxide reductase,
redox regulation ofDNA binding by transcription factors such
as nuclear factor-KB and AP-1, and maintenance of the redox
balance of cells, the recognition of Secys as a component of
mammalian TR is especially significant (28). Previously the
selenium-dependent glutathione peroxidases were the only
Secys-containing enzymes known to have essential roles in
antioxidant processes. The availability of the two NADPH-
linked enzymes, TR and glutathione reductase, whose roles are
to maintain levels of reduced thioredoxins and reduced glu-
tathione in the cell, ensures the optimal function of numerous
essential processes.
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